SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5fsg'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 6	VAL A-364 VAL A-322 ILE A-312 ASN A-105	None	0.88A	1e06A-5fsgA: undetectable	1e06A-5fsgA: 11.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_A_CLMA1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	GLY A 204 THR A 127 ILE A 123 TYR A 206	None	0.79A	1usqA-5fsgA: undetectable	1usqA-5fsgA: 10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HJH_A_NCAA900_0 (NAD-DEPENDENT HISTONE DEACETYLASE SIR2)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 5	ILE A 325 PHE A 332 PHE A 331 ILE A 305	None	1.16A	2hjhA-5fsgA: undetectable	2hjhA-5fsgA: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_A_CLMA1144_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	GLY A 204 THR A 127 ILE A 123 TYR A 206	None	0.79A	2jklA-5fsgA: undetectable	2jklA-5fsgA: 10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_C_CLMC1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	GLY A 204 THR A 127 ILE A 123 TYR A 206	None	0.82A	2jklC-5fsgA: undetectable	2jklC-5fsgA: 10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_C_CLMC1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	PRO A 207 GLY A 204 THR A 127 ILE A 123	None	0.83A	2jklC-5fsgA: undetectable	2jklC-5fsgA: 10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_D_CLMD1145_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	GLY A 204 THR A 127 ILE A 123 TYR A 206	None	0.78A	2jklD-5fsgA: undetectable	2jklD-5fsgA: 10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_D_CLMD1145_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	PRO A 207 GLY A 204 THR A 127 ILE A 123	None	0.86A	2jklD-5fsgA: undetectable	2jklD-5fsgA: 10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_F_CLMF1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	GLY A 204 THR A 127 ILE A 123 TYR A 206	None	0.77A	2jklF-5fsgA: undetectable	2jklF-5fsgA: 10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_F_CLMF1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	PRO A 207 GLY A 204 THR A 127 ILE A 123	None	0.85A	2jklF-5fsgA: undetectable	2jklF-5fsgA: 10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6O_A_SAMA500_0 (HYPOTHETICAL PROTEIN)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	VAL A-275 ALA A-267 PHE A-280 PRO A-281	None	0.84A	2q6oA-5fsgA: undetectable	2q6oA-5fsgA: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A51_C_VDYC6178_1 (VITAMIN D HYDROXYLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	ILE A-264 LEU A-110 ILE A-313 VAL A-349 LEU A-352	None	0.98A	3a51C-5fsgA: undetectable	3a51C-5fsgA: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B6H_A_MXDA551_1 (PROSTACYCLIN SYNTHASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 6	ALA A-184 LEU A-180 ALA A -26 THR A -27	None	0.77A	3b6hA-5fsgA: undetectable	3b6hA-5fsgA: 21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B6H_B_MXDB551_1 (PROSTACYCLIN SYNTHASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 6	ALA A-184 LEU A-180 ALA A -26 THR A -27	None	0.80A	3b6hB-5fsgA: undetectable	3b6hB-5fsgA: 21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 6	PHE A-114 ALA A-210 LEU A-125 PRO A-213	None	1.00A	3bgdA-5fsgA: undetectable	3bgdA-5fsgA: 17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 7	VAL A-262 GLY A -72 PRO A-143 LYS A -67	None	0.75A	3bjwC-5fsgA: undetectable	3bjwC-5fsgA: 12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_G_SVRG506_1 (PHOSPHOLIPASE A2)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 8	VAL A-262 GLY A -72 PRO A-143 LYS A -67	None	0.92A	3bjwA-5fsgA: undetectable	3bjwA-5fsgA: 12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DEU_A_SALA301_1 (TRANSCRIPTIONAL REGULATOR SLYA)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 6	TRP A 239 ARG A 235 ILE A 236 TRP A 232	None	1.12A	3deuA-5fsgA: undetectable	3deuA-5fsgA: 12.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_B_CHDB150_0 (ILEAL BILE ACID-BINDING PROTEIN)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 11	GLN A 375 THR A 369 ILE A 381 TYR A 362 GLN A 378	None	1.26A	3elzB-5fsgA: undetectable	3elzB-5fsgA: 13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_C_CHDC150_0 (ILEAL BILE ACID-BINDING PROTEIN)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	GLN A 375 THR A 369 ILE A 381 TYR A 362 GLN A 378	None	1.29A	3elzC-5fsgA: undetectable	3elzC-5fsgA: 13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM0_A_CHDA150_0 (ILEAL BILE ACID-BINDING PROTEIN)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	GLN A 375 THR A 369 ILE A 381 TYR A 362 GLN A 378	None	1.38A	3em0A-5fsgA: undetectable	3em0A-5fsgA: 13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HS6_A_EPAA1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	VAL A -29 GLY A-185 ALA A-184 LEU A-180 LEU A-212	None	1.01A	3hs6A-5fsgA: undetectable	3hs6A-5fsgA: 21.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	10 / 12	ASP A-358 LYS A-357 GLU A-328 GLU A-327 ALA A-309 ARG A-306 GLU A-261 PRO A-218 TRP A-142 TYR A -31	MTT A1431 (-2.5A) MTT A1431 (-2.7A) MTT A1431 (-2.8A) MTT A1431 (-3.0A) MTT A1431 (-3.2A) MTT A1431 (-3.5A) MTT A1431 (-2.5A) MTT A1431 (-2.8A) MTT A1431 (-3.5A) MTT A1431 (-3.8A)	0.57A	3jyrA-5fsgA: 58.1	3jyrA-5fsgA: 62.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	7 / 7	ASN A-360 TRP A-310 GLU A-219 TYR A-217 MET A -42 TRP A -32 ARG A -28	MTT A1431 (-4.2A) MTT A1431 (-4.1A) MTT A1431 (-3.4A) MTT A1431 (-3.6A) MTT A1431 (-3.7A) MTT A1431 (-3.2A) MTT A1431 (-2.9A)	0.43A	3jyrA-5fsgA: 58.1	3jyrA-5fsgA: 62.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	PHE A-216 GLY A -72 LEU A -73 GLU A-261 ALA A-141	MTT A1431 ( 4.3A) None None MTT A1431 (-2.5A) None	0.89A	3tbgB-5fsgA: undetectable	3tbgB-5fsgA: 22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	PHE A-216 GLY A -72 LEU A -73 GLU A-261 ALA A-141	MTT A1431 ( 4.3A) None None MTT A1431 (-2.5A) None	0.87A	3tbgD-5fsgA: undetectable	3tbgD-5fsgA: 22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	ALA A-141 TYR A-355 TYR A-162 ASN A-138 GLY A-144	None	1.36A	3vwqA-5fsgA: undetectable	3vwqA-5fsgA: 21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWR_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 11	ALA A-141 ASP A -76 TYR A-162 ASN A-138 GLY A-144	None	1.26A	3vwrA-5fsgA: undetectable	3vwrA-5fsgA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_1 (MNMC2)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 5	GLU A -64 ASP A -58 ASP A -85 ASN A -78	None	1.23A	3vywD-5fsgA: undetectable	3vywD-5fsgA: 19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 9	ALA A-108 ALA A-267 LEU A-269 LEU A-110 VAL A-111	None	1.12A	4or0B-5fsgA: undetectable	4or0B-5fsgA: 22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RTM_A_SAMA301_0 (DNA ADENINE METHYLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	GLY A-303 ILE A-106 ASN A-105 TYR A-266 TYR A-273	None	1.03A	4rtmA-5fsgA: undetectable	4rtmA-5fsgA: 18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RTR_A_SAMA301_0 (DNA ADENINE METHYLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 11	GLY A-303 ILE A-106 ASN A-105 TYR A-266 TYR A-273	None	1.09A	4rtrA-5fsgA: undetectable	4rtrA-5fsgA: 18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RTS_A_SAMA301_0 (DNA ADENINE METHYLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 12	GLY A-303 ILE A-106 ASN A-105 TYR A-266 TYR A-273	None	1.08A	4rtsA-5fsgA: undetectable	4rtsA-5fsgA: 18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XJ7_A_ADNA303_1 (5'/3'-NUCLEOTIDASE SURE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 10	GLY A 204 TYR A 206 ALA A 291 ILE A 123 LEU A 205	None	1.23A	4xj7A-5fsgA: undetectable 4xj7B-5fsgA: undetectable	4xj7A-5fsgA: 17.82 4xj7B-5fsgA: 17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E4D_B_BEZB203_0 (HYDROXYNITRILE LYASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	4 / 4	VAL A-262 ALA A-260 ILE A -55 THR A -52	None	1.12A	5e4dB-5fsgA: undetectable	5e4dB-5fsgA: 14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_A_RBFA502_1 (RIBOFLAVIN LYASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	6 / 12	ALA A -30 ALA A -34 GLY A-206 ALA A-184 PHE A-203 VAL A-191	None	1.37A	5w4zA-5fsgA: undetectable	5w4zA-5fsgA: 8.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_B_RBFB502_1 (RIBOFLAVIN LYASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	6 / 12	ALA A -30 ALA A -34 GLY A-206 ALA A-184 PHE A-203 VAL A-191	None	1.40A	5w4zB-5fsgA: undetectable	5w4zB-5fsgA: 8.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_B_RBFB502_1 (RIBOFLAVIN LYASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	6 / 12	SER A -7 ALA A -30 ALA A -34 GLY A-206 ALA A-184 VAL A-191	None	1.31A	5w4zB-5fsgA: undetectable	5w4zB-5fsgA: 8.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7P_B_CHDB401_0 (BILE SALT HYDROLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 10	ILE A 325 LEU A 328 PHE A 331 LEU A 228 ALA A 229	None	1.20A	5y7pB-5fsgA: undetectable	5y7pB-5fsgA: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7P_D_CHDD401_0 (BILE SALT HYDROLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 10	ILE A 325 LEU A 328 PHE A 331 LEU A 228 ALA A 229	None	1.19A	5y7pD-5fsgA: undetectable	5y7pD-5fsgA: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7P_H_CHDH401_0 (BILE SALT HYDROLASE)	5fsg	MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN (Hantaan orthohantavirus)	5 / 10	ILE A 325 LEU A 328 PHE A 331 LEU A 228 ALA A 229	None	1.13A	5y7pH-5fsgA: undetectable	5y7pH-5fsgA: 19.89

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"VAL A-364;VAL A-322;ILE A-312;ASN A-105","None","0.88A","1e06A-5fsgA:undetectable","1e06A-5fsgA:11.92"],["1USQ_A_CLMA1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"GLY A 204;THR A 127;ILE A 123;TYR A 206","None","0.79A","1usqA-5fsgA:undetectable","1usqA-5fsgA:10.90"],["2HJH_A_NCAA900_0","NAD-DEPENDENT HISTONE DEACETYLASE SIR2","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"ILE A 325;PHE A 332;PHE A 331;ILE A 305","None","1.16A","2hjhA-5fsgA:undetectable","2hjhA-5fsgA:19.54"],["2JKL_A_CLMA1144_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"GLY A 204;THR A 127;ILE A 123;TYR A 206","None","0.79A","2jklA-5fsgA:undetectable","2jklA-5fsgA:10.90"],["2JKL_C_CLMC1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"GLY A 204;THR A 127;ILE A 123;TYR A 206","None","0.82A","2jklC-5fsgA:undetectable","2jklC-5fsgA:10.90"],["2JKL_C_CLMC1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"PRO A 207;GLY A 204;THR A 127;ILE A 123","None","0.83A","2jklC-5fsgA:undetectable","2jklC-5fsgA:10.90"],["2JKL_D_CLMD1145_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"GLY A 204;THR A 127;ILE A 123;TYR A 206","None","0.78A","2jklD-5fsgA:undetectable","2jklD-5fsgA:10.90"],["2JKL_D_CLMD1145_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"PRO A 207;GLY A 204;THR A 127;ILE A 123","None","0.86A","2jklD-5fsgA:undetectable","2jklD-5fsgA:10.90"],["2JKL_F_CLMF1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"GLY A 204;THR A 127;ILE A 123;TYR A 206","None","0.77A","2jklF-5fsgA:undetectable","2jklF-5fsgA:10.90"],["2JKL_F_CLMF1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"PRO A 207;GLY A 204;THR A 127;ILE A 123","None","0.85A","2jklF-5fsgA:undetectable","2jklF-5fsgA:10.90"],["2Q6O_A_SAMA500_0","HYPOTHETICAL PROTEIN","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"VAL A-275;ALA A-267;PHE A-280;PRO A-281","None","0.84A","2q6oA-5fsgA:undetectable","2q6oA-5fsgA:19.63"],["3A51_C_VDYC6178_1","VITAMIN D HYDROXYLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"ILE A-264;LEU A-110;ILE A-313;VAL A-349;LEU A-352","None","0.98A","3a51C-5fsgA:undetectable","3a51C-5fsgA:22.32"],["3B6H_A_MXDA551_1","PROSTACYCLIN SYNTHASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"ALA A-184;LEU A-180;ALA A -26;THR A -27","None","0.77A","3b6hA-5fsgA:undetectable","3b6hA-5fsgA:21.59"],["3B6H_B_MXDB551_1","PROSTACYCLIN SYNTHASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"ALA A-184;LEU A-180;ALA A -26;THR A -27","None","0.80A","3b6hB-5fsgA:undetectable","3b6hB-5fsgA:21.59"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"PHE A-114;ALA A-210;LEU A-125;PRO A-213","None","1.00A","3bgdA-5fsgA:undetectable","3bgdA-5fsgA:17.39"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"VAL A-262;GLY A -72;PRO A-143;LYS A -67","None","0.75A","3bjwC-5fsgA:undetectable","3bjwC-5fsgA:12.31"],["3BJW_G_SVRG506_1","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"VAL A-262;GLY A -72;PRO A-143;LYS A -67","None","0.92A","3bjwA-5fsgA:undetectable","3bjwA-5fsgA:12.31"],["3DEU_A_SALA301_1","TRANSCRIPTIONAL REGULATOR SLYA","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"TRP A 239;ARG A 235;ILE A 236;TRP A 232","None","1.12A","3deuA-5fsgA:undetectable","3deuA-5fsgA:12.46"],["3ELZ_B_CHDB150_0","ILEAL BILE ACID-BINDING PROTEIN","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"GLN A 375;THR A 369;ILE A 381;TYR A 362;GLN A 378","None","1.26A","3elzB-5fsgA:undetectable","3elzB-5fsgA:13.62"],["3ELZ_C_CHDC150_0","ILEAL BILE ACID-BINDING PROTEIN","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"GLN A 375;THR A 369;ILE A 381;TYR A 362;GLN A 378","None","1.29A","3elzC-5fsgA:undetectable","3elzC-5fsgA:13.62"],["3EM0_A_CHDA150_0","ILEAL BILE ACID-BINDING PROTEIN","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"GLN A 375;THR A 369;ILE A 381;TYR A 362;GLN A 378","None","1.38A","3em0A-5fsgA:undetectable","3em0A-5fsgA:13.62"],["3HS6_A_EPAA1_1","PROSTAGLANDIN G\/H SYNTHASE 2","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"VAL A -29;GLY A-185;ALA A-184;LEU A-180;LEU A-212","None","1.01A","3hs6A-5fsgA:undetectable","3hs6A-5fsgA:21.19"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",10,"ASP A-358;LYS A-357;GLU A-328;GLU A-327;ALA A-309;ARG A-306;GLU A-261;PRO A-218;TRP A-142;TYR A -31","MTT A1431 (-2.5A);MTT A1431 (-2.7A);MTT A1431 (-2.8A);MTT A1431 (-3.0A);MTT A1431 (-3.2A);MTT A1431 (-3.5A);MTT A1431 (-2.5A);MTT A1431 (-2.8A);MTT A1431 (-3.5A);MTT A1431 (-3.8A)","0.57A","3jyrA-5fsgA:58.1","3jyrA-5fsgA:62.30"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",7,"ASN A-360;TRP A-310;GLU A-219;TYR A-217;MET A -42;TRP A -32;ARG A -28","MTT A1431 (-4.2A);MTT A1431 (-4.1A);MTT A1431 (-3.4A);MTT A1431 (-3.6A);MTT A1431 (-3.7A);MTT A1431 (-3.2A);MTT A1431 (-2.9A)","0.43A","3jyrA-5fsgA:58.1","3jyrA-5fsgA:62.30"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"PHE A-216;GLY A -72;LEU A -73;GLU A-261;ALA A-141","MTT A1431 ( 4.3A);None;None;MTT A1431 (-2.5A);None","0.89A","3tbgB-5fsgA:undetectable","3tbgB-5fsgA:22.50"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"PHE A-216;GLY A -72;LEU A -73;GLU A-261;ALA A-141","MTT A1431 ( 4.3A);None;None;MTT A1431 (-2.5A);None","0.87A","3tbgD-5fsgA:undetectable","3tbgD-5fsgA:22.50"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"ALA A-141;TYR A-355;TYR A-162;ASN A-138;GLY A-144","None","1.36A","3vwqA-5fsgA:undetectable","3vwqA-5fsgA:21.41"],["3VWR_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"ALA A-141;ASP A -76;TYR A-162;ASN A-138;GLY A-144","None","1.26A","3vwrA-5fsgA:undetectable","3vwrA-5fsgA:21.11"],["3VYW_D_SAMD401_1","MNMC2","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"GLU A -64;ASP A -58;ASP A -85;ASN A -78","None","1.23A","3vywD-5fsgA:undetectable","3vywD-5fsgA:19.13"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"ALA A-108;ALA A-267;LEU A-269;LEU A-110;VAL A-111","None","1.12A","4or0B-5fsgA:undetectable","4or0B-5fsgA:22.68"],["4RTM_A_SAMA301_0","DNA ADENINE METHYLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"GLY A-303;ILE A-106;ASN A-105;TYR A-266;TYR A-273","None","1.03A","4rtmA-5fsgA:undetectable","4rtmA-5fsgA:18.12"],["4RTR_A_SAMA301_0","DNA ADENINE METHYLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"GLY A-303;ILE A-106;ASN A-105;TYR A-266;TYR A-273","None","1.09A","4rtrA-5fsgA:undetectable","4rtrA-5fsgA:18.12"],["4RTS_A_SAMA301_0","DNA ADENINE METHYLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"GLY A-303;ILE A-106;ASN A-105;TYR A-266;TYR A-273","None","1.08A","4rtsA-5fsgA:undetectable","4rtsA-5fsgA:18.12"],["4XJ7_A_ADNA303_1","5'\/3'-NUCLEOTIDASE SURE;5'\/3'-NUCLEOTIDASE SURE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"GLY A 204;TYR A 206;ALA A 291;ILE A 123;LEU A 205","None","1.23A","4xj7A-5fsgA:undetectable;4xj7B-5fsgA:undetectable","4xj7A-5fsgA:17.82;4xj7B-5fsgA:17.82"],["5E4D_B_BEZB203_0","HYDROXYNITRILE LYASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",4,"VAL A-262;ALA A-260;ILE A -55;THR A -52","None","1.12A","5e4dB-5fsgA:undetectable","5e4dB-5fsgA:14.90"],["5W4Z_A_RBFA502_1","RIBOFLAVIN LYASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",6,"ALA A -30;ALA A -34;GLY A-206;ALA A-184;PHE A-203;VAL A-191","None","1.37A","5w4zA-5fsgA:undetectable","5w4zA-5fsgA:8.19"],["5W4Z_B_RBFB502_1","RIBOFLAVIN LYASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",6,"ALA A -30;ALA A -34;GLY A-206;ALA A-184;PHE A-203;VAL A-191","None","1.40A","5w4zB-5fsgA:undetectable","5w4zB-5fsgA:8.19"],["5W4Z_B_RBFB502_1","RIBOFLAVIN LYASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",6,"SER A  -7;ALA A -30;ALA A -34;GLY A-206;ALA A-184;VAL A-191","None","1.31A","5w4zB-5fsgA:undetectable","5w4zB-5fsgA:8.19"],["5Y7P_B_CHDB401_0","BILE SALT HYDROLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"ILE A 325;LEU A 328;PHE A 331;LEU A 228;ALA A 229","None","1.20A","5y7pB-5fsgA:undetectable","5y7pB-5fsgA:19.89"],["5Y7P_D_CHDD401_0","BILE SALT HYDROLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"ILE A 325;LEU A 328;PHE A 331;LEU A 228;ALA A 229","None","1.19A","5y7pD-5fsgA:undetectable","5y7pD-5fsgA:19.89"],["5Y7P_H_CHDH401_0","BILE SALT HYDROLASE","5fsg","MALTOSE-BINDING PERIPLASMIC PROTEIN, HANTAVIRUS NUCLEOPROTEIN","Hantaan orthohantavirus",5,"ILE A 325;LEU A 328;PHE A 331;LEU A 228;ALA A 229","None","1.13A","5y7pH-5fsgA:undetectable","5y7pH-5fsgA:19.89"]]